DGfI welcomes MABTECH AB as Corporate Member

The "German Society for Immunology (DGfI)" and "MABTECH AB" are proud to inform you about their registration as "Corporate Member", starting 2011. This underlines the attractiveness of our society for companies in the area of Immunology. The Corporate Membership offers for companies many advantages, such as a discount for the booth at our Annual Meetings or a direct link between the company and our Society, e.g. in order to drive projects faster with more specialized knowledge. We look forward to a benefiting partnership for both parties.

About DGfI:
The German Society for Immunology is a registered association. Our aim is to develop Immunology as a scientific and clinical field in Germany. Especially we encourage scientific basic research as itself as well as to support new scientist in the field of Immunology. With our more than 2.100 personal members and a yearly member-growth of more than 5% in the last years, we are after more than 40 years of our foundation now more than ever an attractive partner for Scientist, Hospitals and Cooperations. Another milestone is our yearly annual meeting in Riccione, Italy, (28.Sept.-01.Oct.2011), this time a bi-national congress, together with our italian Partner-Society, SIICA. We expect more than 1.000 Imunologists and about 50 Cooperations from Germany, Italy and other countries.

About MABTECH AB:
Mabtech AB is a privately owned biotech company founded in 1986. Emerging from the Department of Immunology at the Stockholm University, the company has become a world leader in the development of products for measuring antigen-specific responses by B and T cells.
As one of the most sensitive and easiest methods to analyze antigen-specific immune responses at the single cell level, the ELISpot assay is ideal whenever studying the roles of T and B cells in e.g. infections, cancer, allergy and autoimmune disease. With its straightforward protocol and the ability to screen large number of samples, the ELISpot assay has become a standard method in the research and clinical evaluations of new vaccines.
Mabtech offers a large number of ELISpot kits and reagents enabling investigations of cellular responses in human, non-human primates, mouse as well as other species.
To enable a more detailed qualitative analysis of antigen-specific T cells, we have also developed the FluoroSpot assay. Fluorescent visualization allows simultaneous detection of more than one cytokine and can be used for the demonstration of polyfunctional T cells or in situations where cell numbers are limited.
Through innovative development and high quality standards, we provide products that meet the needs of the frontline researcher and those involved in clinical research requiring large scale screening under standardized conditions.

Further Information:
Alexander Weitz
Deutsche Gesellschaft für Immunologie e.V., Kfm. Geschäftsführung
German Society for Immunology, Executive Secretary Administration
DGfI c/o DRFZ, Chariteplatz 1, 10117 Berlin (DE)
mail@dgfi.org, www.dgfi.org

www.immunologie.de, corporate-member.dgfi.org, www.mabtech.com

This release was published on openPR.